HomeAbout

TL;DR CNBC


Regeneron requests emergency use approval for antibody treatment taken by Trump; stock rises 4% in premarket - TL;DR CNBC

Regeneron requests emergency use approval for antibody treatment taken by Trump; stock rises 4% in premarket

Publishing timestamp: 2020-10-08 10:16:53


Summary


Sentiment: NEGATIVE

Tickers: ROG-CHREGN

Keywords:

Source: https://www.cnbc.com/2020/10/08/regeneron-requests-eua-from-the-fda-for-coronavirus-treatment.html


Developed by Leo Phan